Few would place Recursion Pharmaceuticals (NASDAQ: RXRX), a little-known biotech company, in the same league as these tech ...

In a Q&A, Recursion’s incoming CEO acknowledges hype around the idea of using AI to expedite drug development, and says it's ...

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week.

We consider a multivariate distributional recursion of sum type, as arises in the probabilistic analysis of algorithms and random trees. We prove an upper tail bound for the solution using Chernoff's ...

SALT LAKE CITY--(BUSINESS WIRE)--Recursion, a Fast Company “Most Innovative Company” and leader in the artificial intelligence for drug discovery movement, today announced it will open-source a ...

This is a preview. Log in through your library . Abstract A scale-free tree with the parameter β is very close to a star if β is just a bit larger than — 1, whereas it is close to a random recursive ...

Is that the case? Let's look into it and decide whether the company is worth investing in.

Dr. James McCaffrey presents a complete end-to-end demonstration of decision tree regression from scratch using the C# language. The goal of decision tree regression is to predict a single numeric ...